Polycystic Kidney Disease Treatment Network

horizontal rule

HALT PKD

horizontal rule

HALT PKD Clinical Research

The Polycystic Kidney Disease Treatment Network (PKD-TN) has established the HALT PKD clinical trials to test interventions that may be effective in slowing kidney growth in patients suffering from polycystic kidney disease.  Top investigators from a number of leading United States medical centers, with full support from the NIH National Institute of Diabetes & Digestive & Kidney Diseases, are collaborating in HALT PKD clinical trials.  The Division of Biostatistics at Washington University in St. Louis serves as the Data Coordinating Center (DCC), under the guidance of Professor J. Philip Miller.  The DCC is responsible for developing a Web-based data entry system, managing all study data, tracking patient recruitment and adverse events, and overseeing data collection and reporting.
 

bullet Beth Israel Deaconess Medical Center
 
bullet Cleveland Clinic Foundation
 
bullet Emory University
 
bullet Mayo Clinic
 
bullet Tufts Medical Center
 
bullet University of Colorado Health Sciences Center
 
bullet University of Kansas Medical Center
 
bullet Washington University in St. Louis


*Please note that final determination of eligibility to participate in any clinical trial requires that the principal investigator or his/her designate make a very subject-specific, case-by-case assessment based on defined inclusion/exclusion criteria.
 

Resources for Information on HALT PKD and Polycystic Kidney Disease

bulletHALT PKD: Information for Physicians Brochure (pdf)
 
bulletHALT PKD: ClinicalTrials.gov

Information on the specific aims of the HALT PKD study, the eligibility requirements for study participation, and the individuals to contact if you are interested in being considered for the study, may be found at ClinicalTrials.gov, a website sponsored by the U.S. National Institutes of Health (NIH) to link patients to medical research.
 
bulletPKD Foundation

The PKD Foundation is the only organization, worldwide, devoted to determining the cause, improving clinical treatment and discovering a cure for Polycystic Kidney Disease (PKD).
 
bullet Clinical Trials Update
 
bullet U.S. National Institute of Diabetes & Digestive & Kidney Diseases of the National Institutes of Health
 
bullet RFA - Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Research Studies (R01)

 

Participate in HALT PKD Studies

bulletParticipant recruitment is now underway!
Information on study participation may be found by referring to the HALT PKD study brochure - just click on the link below:.
 
bullet HALT PKD Study Brochure (pdf)

           

 
bulletStudy participants will be followed at participating clinic sites, which are assigned according to the state they live in.  If you are interested in participating in HALT PKD, you can determine the clinic site where you would be followed by looking up your state below.  Once you have located your state, please feel free to contact the study coordinator at the phone number listed for that site.  She would be very pleased to provide you with more information about participating in HALT PKD.
 
bulletThe HALT PKD Project Manager would also be pleased to talk about study participation with you.  She can be reached by phone at (314) 362-1318 or by email by clicking on this link: HALT PKD Project Manager. She will ask you for your contact information so she can send it to the study coordinator at the clinic site nearest your home.  The study coordinator will then get in touch with you for a prescreening interview.
 

If you live in one of these Eastern states:

Connecticut, Delaware, District of Columbia, Maine, Maryland, Massachusetts, Pennsylvania, New Hampshire, New Jersey, New York, Rhode Island, Vermont, or Virginia - please call:

Tufts Medical Center – Boston, MA
1-866-846-2735
(toll-free)

Beth Israel Deaconess Medical Center – Boston, MA
1-866-650-1815 (toll-free)

If you live in one of these Southern states:

Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, or Tennessee - please call:

Emory University – Atlanta, Georgia
1-404-686-8280 (new #)

If you live in one of these Midwestern states:

Arkansas, Iowa, Illinois, Indiana, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South Dakota, West Virginia, or Wisconsin - please call:

Mayo Clinic – Rochester, Minnesota
1-888-630-2616
(toll-free)

Cleveland Clinic Foundation – Cleveland, Ohio
1-800-223-2273, Ext. 44680 (toll-free)

Kansas University Medical Center – Kansas City, Kansas
1-913-588-7609

If you live in one of these Western states:

Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Texas, Utah, Washington, or Wyoming - please call:

University of Colorado Health Sciences Center
Denver, Colorado
1-877-765-9297 (toll-free)

horizontal rule

Portions of the PKD-TN web site may be
accessed by only authorized study investigators.

To apply for authorization to access user-restricted sections of the
PKD-TN/HALT PKD Web Site, please download
Form #A-1 (Word Document).

Investigator Log-In   °   DSMB Log-In

Manual of Procedures (html)   °   Manual of Procedures (pdf)

Web Data Entry System   °   Web-Based Reports

Data Coordinating Center   °   DCC Sidedoor

For more information on PKD-TN/HALT PKD, please contact the Project Manager:  Robin Woltman.

horizontal rule

Hosted by
Washington University in St. Louis - School of Medicine
Division of Biostatistics

For problems or questions regarding this web site, please contact
[Robin Woltman].
Last updated: 05/15/08.